Chemours Company (the) · NYSE:CC
Chemours Company (the) — Investor Day (December 2017)
7 slides from Chemours Company (the)'s investor day presentation, Dec 1, 2017
Slide 1: 2017 Investor Day Non-GAAP Reconciliations
€ Chemours- The Chemours Company 2017 Investor Day Non-GAAP Reconciliations December 1, 2017
Slide 2: Safe Harbor
Safe Harbor ‘This presentation contains forward ooking statements, within the meaning of he safe harbor provisions ofthe US, Private Secures Litigation Reform Act of 1995, which inno nsks and uncertainties. Forvard-looking statements provide curent expectations of fue eveats based on certain assumpt
Slide 3: = =a = ar a
= =a = ar a CS a ° ° a z 5 a
Slide 4: Segment Adjusted EBITDA Tabular Reconciliations (Unaudited)
€ Chemours- Segment Adjusted EBITDA Tabular Reconciliations (Cnandied) (Dollars in milion) ‘Twelve Months Ended September 30, 2017 ‘Titniuan Technologies s 36S 4665S 758 Flucroprodcts 300 4s en (Chemical Soktions 29 29 46 CComporate and Otber Adjusted EBITDA * " See"GAAP Net (Loss) Income Ansibutble
Slide 5: Adjusted EBITDA to ROIC Tabular Reconciliations (Unaudited)
€ chemours: Ajased EBITDA to ROIC Tabular Reon Cand) (Dollars ix milion) ‘Twelve Months Ended September 30, 2017 ‘Adjusted EBITDA s as 1267 Less: Depreciation and amortization Adjusted EBIT oval debe Total equity Less: Cashand cash oquivalents 365) (02) 539) Invested capital, net s 3718S 2746S 3365,
Slide 6: Adjusted EBITDA to Net Leverage Tabular Reconciliations (Unaudited)
€ Chemours- Adjusted EBITDA to Net Leverage Tabular Reconciliations (Cnauited) (ollars in milion) ‘Twelve Months Year Ended December 31, ‘Adjusted EBITDA” s mS ams 1267 ‘Tord debe Less: Cash and cash equivalents Debi, net Netleverage 626 321 20 * See"GAAP Net (Loss) Income Armibuable to Chemours to
Slide 7: Ecvenaire cercramenth ita
Ecvenaire cercramenth ita oa mie pr se